Skip to main content

Singular Genomics Systems, Inc.

OMICDelisted Feb 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0001850906

Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.

Q2 2023 vs. Q1 2023

How the institutions holding Singular Genomics Systems, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of OMIC: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders6662−4
Shares35.8M32.8M−2.98M (−8.3%)
Value$43.4M$27.3M−$16.1M (−37.1%)

New holders (15)

Institutions that held Singular Genomics Systems, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to OMIC in Q2 2023
InstitutionSharesValue% of portfolio
Millennium Management LLC859,698$713.5K0.00%
Acuitas Investments, LLC661,888$549.4K0.32%
Bank of Montreal524,140$461.2K0.00%
Verition Fund Management LLC480,000$398.4K0.01%
Jacobs Levy Equity Management, Inc205,583$170.6K0.00%
Y-Intercept (Hong Kong) Ltd154,007$127.8K0.01%
Old Mission Capital LLC95,067$78.9K0.00%
Qube Research & Technologies Ltd85,068$70.6K0.00%
Jane Street Group, LLC50,340$41.8K0.00%
Point72 Middle East FZE19,568$16.2K0.00%
Balyasny Asset Management LLC13,897$11.5K0.00%
Engineers Gate Manager LP13,350$11.1K0.00%
Point72 Asset Management, L.P.7,437$6.17K0.00%
Cubist Systematic Strategies, LLC6,098$5.06K0.00%
Citigroup Inc129$1070.00%

Sold out (19)

Institutions that held Singular Genomics Systems, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.